Clinical Trial Update: Safety and Efficacy of Zuretinol Acetate in Subjects With Inherited Retinal Disease [Phase 2, Phase 3]

View source ↗

Summary

A clinical trial evaluating Zuretinol Acetate for inherited retinal disease has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Inherited Retinal Disease

Drugs mentioned

• Zuretinol Acetate (zuretinol acetate)

Snippet

Sponsor: Retinagenix Holdings | Conditions: Retinal Disorder | Phase 2, Phase 3 | Status: WITHDRAWN